3Barone M, Ettorre GC, Ladisa R, et al. Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma. Hepatogastroenterology, 2003, 50:183-187.
4Caturelli E, Siena DA, Fusilli S,et al.Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study. Radiology, 2000, 215:123-128.
5Sakamoto I, Iwanaga S, Nagaoki K,et al. Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. AJR Am J Rentgenol, 2003, 181:79-87.
6Yu JS, Kim KW, Jeong MG, et al. Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy. CardioVascular and Interventional Radiology, 2002, 25:270-274.
7Yu JS, Kim KW, Park MS, et al. Bile duct injuries leading to portal vein obliteration after transcatheter arterial chemoembolization in the liver: CT findings and initial observations. Radiology,2001,221:429-436.
8Kim HK, Chung YH, Song BC, et al. Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol, 2001, 32:423-427.
9Kobayashi S, Nakanuma Y, Terada T, et al. Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization therapy: Relevance to microvascular damages of peribiliary capillary plexus. Am J Gastroenterol, 1993,88:1410-1415.
10Tarazov PG, Polysalov VN, Prozorovskij KV, et al. Ischemic complications of transcatheter arterial chemoembolization in liver malignancies. Acta Radiol, 2000, 41:156-160.
